Respiratory syncytial virus infection in adults aged 45 years or older is significantly associated with a higher 1-year risk ...

According to the Florida Department of Health, flu cases and emergency visits have been increasing across the state. In ...

Federal regulators have begun a safety review of two RSV medicines used to protect infants, even though no safety problems ...

FDA turns up the heat: Federal regulators are requesting more safety information from drugmakers on products meant to protect ...

The U.S. Centers for Disease Control and Prevention (CDC) recommends Beyfortus or Enflonsia for babies younger than 8 months ...

The drugs are essentially laboratory-made versions of natural antibodies that help the immune system fight off RSV. The FDA ...

Learn what happens to cells inside the nose during an RSV infection, and why infants are so vulnerable to the virus.

Health professionals in B.C. are asking parents to be vigilant this respiratory season as ER and primary care centre visits ...

Wash your hands and cover your mouth. Here are more simple tips on how to prevent winter illnesses as we head into the ...

The dashboard provides a data-driven overview of local trends for flu, respiratory syncytial virus (RSV), and COVID-19, ...

Doctors said that avoiding crowds, washing hands often, keeping sick kids home and knowing the warning signs of flu and RSV ...

Sanofi and AstraZeneca’s Beyfortus (Nirsevimab) is now approved by the National Pharmaceutical Regulatory Agency (NPRA) and ...